Clinical documentation company MedQuist Inc. yesterday announced its intentions to apply for listing of its common stock next month on the NASDAQ Global Select Market.
The firm, based in Mount Laurel, N. J., said it also plans to file a preliminary proxy statement with the Securities and Exchange Commission on or around Nov. 9, in anticipation of its first annual shareholders meeting since 2003. At the meeting, expected to take place within 30 days of a definitive proxy statement, shareholders will have the opportunity to elect members of the company’s Board of Directors.
Since it was delisted from the NASDAQ National Market in June of 2004, MedQuist has traded over the counter under the symbol "MEDQ.PK.”
Royal Philips Electronics holds an approximate 70 percent stake in the company.
